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Abstract
Hemangioma is the most common benign tumor of the liver. Liver hemangioma (LH) usually remains
asymptomatic, but the most common symptoms associated with LH are abdominal pain and discomfort. LH is an
uncommon cause of bile duct dilatation and obstructive jaundice. An 83-year-old Japanese woman who received
hemodialysis at another hospital was referred to our hospital because of abnormal liver function and obstructive
jaundice. Abdominal computed tomography and magnetic resonance imaging revealed a 13-cm tumor in liver
segments IV–V and intrahepatic bile duct dilatation. Endoscopic retrograde cholangiopancreatography revealed
extrinsic compression of the bile duct at the hepatic hilar region. Laboratory tests showed that the patient had low
platelet counts and low fibrinogen levels. Because the patient had hyperbilirubinemia and Kasabach-Merritt
syndrome, we performed a segmentectomy of liver segments IV and V. Histological examination showed
hemangioma of the liver. The patient’s thrombocytopenia and coagulopathy improved immediately after surgery. In
conclusion, LH is a very rare cause of obstructive jaundice. LH has the potential to compress the bile duct and
cause obstructive jaundice.
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Background
Liver hemangioma (LH) is the most common benign
tumor arising in the liver, with an estimated prevalence of
0.4 to 7.3 % in the general population [1, 2]. Most LHs are
reported to be asymptomatic. However, in patients under-
going surgery for hemangioma, 65 % of hemangiomas are
symptomatic, with abdominal pain or discomfort being the
most common symptoms [3]. The typical hemangioma is
relatively small (<2 cm), but larger LH sometimes are
observed, some measuring up to 30 cm in diameter. Biliary
obstruction is a very rare manifestation of hemangioma.
We present a case with obstructive jaundice due to LH
coexisting with Kasabach-Merritt syndrome, together with
a discussion of the related medical literature.
Case presentation
An 83-year-old woman with diabetes mellitus, hyper-
tension, and spinal canal stenosis who was undergoing
hemodialysis for chronic renal failure was admitted to an-
other hospital, with itching as the chief complaint. She had
notable hyperbilirubinemia (total bilirubin (T-Bil), 4.6 mg/
dl; direct bilirubin (D-Bil), 3.7 mg/dl; alkaline phosphatase
(ALP), 1333 U/L; gamma glutamyl transpeptidase (γ-GTP),
350 U/L) in blood examination. Abdominal echography
examination revealed intrahepatic bile duct dilatation and
computed tomography (CT) showed a 13-cm mass in the
right lobe of the liver. Endoscopic retrograde cholangiopan-
creatography (ERCP) revealed extrinsic compression of the
bile duct at the hepatic hilar region.
To improve the jaundice, endoscopic nasobiliary drainage
was performed and yielded gradual improvements in the
jaundice. At the same time, biliary cytology was performed.
The architecture was disturbed, characterized by variation
in internuclear distances and dyskaryosis. Therefore, the
liver tumor was diagnosed as suspicious for malignancy.
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The patient was transferred to our hospital for hepatic
tumor therapy.
Laboratory tests of biliary enzymes showed an im-
provement (T-Bil, 1.1 mg/dl; D-Bil, 0.6 mg/dl; ALP, 600
U/L; γ-GTP, 57 U/L) but revealed blood coagulopathy
(platelet count, 9.6 × 103 per cubic millimeter; fibrinogen,
122.5 mg/dl; fibrinogen and fibrin degradation products
(FDP), 200 μg/ml; D-dimer, 88.8 μg/ml).
CT revealed a huge mass without enhancement, with a
diameter of 13 cm, and clear boundaries in the anterior and
medial sections of the liver. The tumor caused compression
of a bile duct in the hepatic hilar region and intrahepatic
bile ducts were dilated (Fig. 1a).
Previous CT scans 5 years ago at our hospital
showed that the size of a tumor at the same locus was
28 mm (Fig. 1b).
A low signal on the T1-weighted image and a slightly
high signal on the T2-weighted image were observed by
using magnetic resonance imaging (MRI) (Fig. 1c).
A stricture of approximately 2 cm was observed in the
common bile duct on ERCP and suspected to be a result
of compression from the outside wall, causing partial
expansion of a right lobe bile duct and high expansion of
the left lobe bile duct (Fig. 1d).
The preoperative diagnosis was suspected to be cav-
ernous hemangioma, but differential diagnosis suggested
hemangioendothelioma and hepatic echinococcosis. Be-
cause of the malignant potential of the tumor and the
coexistence of Kasabach-Merritt syndrome, surgery was
performed.
Operative findings macroscopically showed a normal
liver with a soft and multilocular 13-cm tumor localized
in Segment IV–Segment V. A segmentectomy of the liver
segments IV and V was performed with resection of the
middle hepatic vein. We confirmed that a stricture of a
bilateral hepatic duct was removed using intraoperative
cholangiography. The intraoperative bleeding volume was
1930 ml. She received transfusion of 4 units of red blood
cell transfusion, 5 units of fresh frozen plasma, and 10
units of platelet transfusion during the intraoperative
period. She did not need transfusion before and after
operation.
Pathology revealed that the tumor was composed of
cavernous vascular spaces of varying sizes lined by a
single layer of flat endothelium. There was focal stromal
fibrosis, calcification, and hyalinization (Fig. 2). Our final
diagnosis of the patient was cavernous hemangioma of
the liver.
Fig. 1 Radiological findings. a Computed tomography (CT) scan of the abdomen showing a well-demarcated liver mass consistent with hemangioma
in the anterior segment of the right hepatic lobe to segment IV. The tumor pressed a bile duct in the hepatic portal region, causing an intrahepatic bile
duct to expand. b A CT scan performed 5 years prior to the study shows a low-density tumor with a diameter of 28 mm in the right lobe. c The size of
the tumor was shown to be 13 cm in diameter in magnetic resonance imaging, with a clearly demarcated border and a heterogeneous signal on
T2-weighted images. The tumor had a fluid-fluid level at the tumor margins. d A stricture of approximately 2 cm in length in the common bile duct
was observed via endoscopic retrograde cholangiography and suspected to be a result of compression from the outside wall. This caused partial
expansion of a right lobe bile duct and high expansion of the left lobe bile duct
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Postoperative cholangiography did not show a biliary
stricture. After surgical resection of the hemangioma,
blood coagulopathy improved (Fig. 3) (platelet count,
183 per cubic millimeter; fibrinogen, 328.1 mg/dl, FDP,
24.4 μg/ml; D-dimer, 12.6 μg/ml), and the patient was able
to resolve her thrombocytopenia and coagulopathy.
Discussion
Most patients with cavernous hemangioma are asymptom-
atic but a minority present with abdominal pain or abdom-
inal distension. Hemangiomas have been identified at
autopsy in up to 7 % of patients and are more common in
women than in men [1]. Lesions are usually dark red and
Fig. 2 Gross and histological findings. a The tumor was wine colored and elastic. b The tumor was composed of blood-filled spaces lined by a
single layer of endothelial cells without smooth muscle (H&E staining, objective; ×40). c Fibrotic, hyalinized, and calcified lesions were observed


























Fig. 3 Clinical course of coagulopathy. After surgery, blood coagulopathy was improved immediately
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well circumscribed, but the macroscopic appearance can
vary because of thrombosis, fibrosis, and calcification.
Histologically, cavernous hemangiomas are composed
of blood-filled spaces lined by a single layer of endo-
thelial cells and supported by a basement membrane.
Fibrosis is variable but may involve the entire lesion
(sclerosed hemangioma). Rare complications include
spontaneous rupture, traumatic rupture, portal hyper-
tension, and coagulopathy. The identification of hem-
angiomas using radiological imaging can be difficult,
but investigations with relatively high sensitivity and
specificity include MRI scans, contrast-enhanced CT,
and nuclear medicine scans using labeled red cells.
Dilatation of the intrahepatic bile ducts can occur as a
result of either compression or tumor spread in patients
with malignant liver tumor, such as (1) tumor spread to
and sheathing of the bile ducts in cholangiocarcinomas,
(2) growing cast within the bile ducts in hepatocellular
carcinomas, and (3) metastatic infiltration of the bile
ducts, particularly in colon adenocarcinoma [4]. Bile
duct dilatation can be an important indicator of malig-
nant liver tumors. In contrast, benign liver tumors are
not considered to be a cause of bile duct dilatation, even
if they are very large [5, 6].
Until now, only two resected adult cases with obstructive
jaundice by cavernous hemangioma have been reported in
the English literature (Table 1) [7, 8]. Including this case, all
cases were observed in women with an age of 31–83 years.
The tumor was 13–20 cm in diameter. One report was of a
biliary stricture caused by a hepatic cyst [6]. The locus of
the hepatic cysts was an existing case close to the hilum.
Even in benign cases, other structures may show the pres-
ence of biliary stricture in lesions close to the hilum [9].
Two hemangioma cases causing the biliary stricture were
close to the hilum similarly. In our case, the tumor was
located in segment IV, close to the hilum. If hemangioma is
close to the hilum, there is a possibility that hemangioma
can cause biliary stricture regardless of tumor size.
The incidence of Kasabach-Merritt syndrome in LH is
around 1.7 % [3], but Kasabach-Merritt syndrome is a
serious complication characterized by a very large
hemangioma with thrombocytopenia and consump-
tion coagulopathy due to endothelial defects within
the hemangioma. In our case, according to CT, the
hemangioma had enlarged over 5 years. The enlarging of
the hemangioma from 5 years ago caused Kasabach-Meritt
syndrome, and the hemangioma, to reach hepatic portal
region. We consider that the hemangioma which was close
to hilum induced bile duct stricture. There is another
speculation about Kasabach-Meritt syndrome and bile duct
stricture. Consumptive coagulopathy due to Kasabach-
Meritt syndrome might cause blood flow disorders of bile
duct. But there were no reports of a hemangioma with
Kasabach-Merritt syndrome as the cause for biliary stric-
ture and development of obstructive jaundice.
There are some reports that estrogen contributes to
hemangioma enlargement [10, 11]. Our case occurred
after menopause in the absence of estrogen intake. How-
ever, the patient received oral prostaglandin E1, which
contains a platelet aggregation inhibitor, to treat spinal
canal stenosis and underwent hemodialysis. We suspected
that the patient developed Kasabach-Merritt syndrome
due to the enlargement of tumor with tendency to bleed.
LHs that are large and symptomatic are usually treated
surgically, either by enucleation or by resection. LHs
require some form of treatment, such as surgical resec-
tion, liver transplantation [12–14], arterial embolization
[15, 16], interferon [17, 18], radiation [19], systemic corti-
costeroids [20], or radiofrequency ablation [21]. In general,
hepatic hemangiomas with Kasabach-Merritt syndrome
should be managed by surgical approaches if resection is
possible [22]. As there are no reports on the use of trans-
catheter arterial embolization therapy or bile duct stents
in cases where the hemangioma causes biliary stricture, as
in this case, surgical resection is currently considered an
effective treatment.
Conclusions
LHs may be enlarged, and those close to the hepatic hilum
may potentially compress the bile duct and cause obstruct-
ive jaundice. Therefore, there is a need to carefully observe
hemangiomas.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
Table 1 Reported cases of liver hemangioma causing biliary stricture
Year First author Age Sex Symptom Laboratory data Location Tumor size Operation
2008 Julian E. Losanoff 42 F Discomfort in the right
hypochondrium and itching
T-Bil 4.2 mg/dl, D-Bil 3.9 mg/dl,
ALP 283 IU/L
Right lobe 15 cm Right hepatectomy
2009 L Tang 31 F Jaundice and amenorrhea T-Bil 292 μmol/l, ALP 575U/l – 20 cm Right hepatectomy
2015 Present 83 F Itching T-Bil 4.6 mg/dl, D-Bil 3.7 mg/dl,
ALP 1333 IU/L
S4-S5 13 cm Segmentectomy
T-Bil total birilubine, D-Bil direct birilubine, ALP alkaline phosphatase
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images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Abbreviations
LH: liver hemangioma; T-Bil: total bilirubin; D-Bil: direct bilirubin; ALP: alkaline
phosphatase; γ-GTP: gamma glutamyl transpeptidase; CT: computed
tomography; ERCP: endoscopic retrograde cholangiopancreatography;
MRI: magnetic resonance imaging.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TY drafted the manuscript. TK treated the patient and helped draft the
manuscript. SK helped draft the manuscript. HA treated the patient. HT and
HO determined the treatment plan and revised the manuscript. All authors
read and approved the final manuscript.
Authors’ information
TY and SK are staff surgeon in the Department of Gastroenterological and
Transplant Surgery, Applied Life Sciences, Institute of Biomedical & Health
Sciences, Hiroshima University. TK and HA are assistant professors in the
Department of Gastroenterological and Transplant Surgery, Applied Life
Sciences, Institute of Biomedical & Health Sciences, Hiroshima University. HT
is an associate professor in the Department of Gastroenterological and
Transplant Surgery, Applied Life Sciences, Institute of Biomedical & Health
Sciences, Hiroshima University. HO is a professor in the Department of
Gastroenterological and Transplant Surgery, Applied Life Sciences, Institute of
Biomedical & Health Sciences, Hiroshima University.
Acknowledgements
We thank Dr Noriyuki Shiroma and Prof Koji Arihiro (Department of
Anatomical Pathology, Hiroshima University) for the pathological diagnosis.
This case report is not supported by any grants.
Received: 22 April 2015 Accepted: 1 October 2015
References
1. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am.
1975;59(4):995–1013.
2. Ochsner JL, Halpert B. Cavernous hemangioma of the liver. Surgery.
1958;43(4):577–82.
3. Yoon SS, Charny CK, Fong Y, Jarnagin WR, Schwartz LH, Blumgart LH,
et al. Diagnosis, management, and outcomes of 115 patients with
hepatic hemangioma. J Am Coll Surg. 2003;197(3):392–402. doi:10.1016/
s1072-7515(03)00420-4.
4. Thomas JH, Pierce GE, Karlin C, Hermreck AS, MacArthur RI. Extrahepatic
biliary obstruction secondary to metastatic cancer. Am J Surg.
1981;142(6):770–3.
5. Charles AR, Gupta AK, Bhatnagar V. Giant congenital solitary cyst of the liver:
report of a case. Surg Today. 2001;31(8):732–4.
6. Ito K, Taira K, Arii S. Intrahepatic bile duct dilatation with a liver cyst and
hemangioma: report of a case. Surg Today. 2009;39(3):256–60. doi:10.1007/
s00595-008-3831-6.
7. Losanoff JE, Millis JM. Liver hemangioma complicated by obstructive
jaundice. Am J Surg. 2008;196(3):e3–4. doi:10.1016/j.amjsurg.2007.08.069.
8. Tang L, Zhou WP. Education and imaging. Hepatobiliary and pancreatic:
large cavernous hemangioma with obstructive jaundice. J Gastroenterol
Hepatol. 2009;24(5):930. doi:10.1111/j.1440-1746.2009.05889.x.
9. Lapeyre M, Mathieu D, Tailboux L, Rahmouni A, Kobeiter H. Dilatation of the
intrahepatic bile ducts associated with benign liver lesions: an unusual
finding. Eur Radiol. 2002;12(1):71–3. doi:10.1007/s003300100867.
10. Xiao X, Hong L, Sheng M. Promoting effect of estrogen on the proliferation of
hemangioma vascular endothelial cells in vitro. J Pediatr Surg. 1999;34(11):1603–5.
11. Conter RL, Longmire Jr WP. Recurrent hepatic hemangiomas. Possible
association with estrogen therapy. Ann Surg. 1988;207(2):115–9.
12. Longeville JH, de la Hall P, Dolan P, Holt AW, Lillie PE, Williams JA, et al.
Treatment of a giant haemangioma of the liver with Kasabach-Merritt
syndrome by orthotopic liver transplant a case report. HPB Surg.
1997;10(3):159–62.
13. Meguro M, Soejima Y, Taketomi A, Ikegami T, Yamashita Y, Harada N, et al.
Living donor liver transplantation in a patient with giant hepatic
hemangioma complicated by Kasabach-Merritt syndrome: report of a case.
Surg Today. 2008;38(5):463–8. doi:10.1007/s00595-007-3623-4.
14. Vagefi PA, Klein I, Gelb B, Hameed B, Moff SL, Simko JP, et al. Emergent
orthotopic liver transplantation for hemorrhage from a giant cavernous
hepatic hemangioma: case report and review. J Gastrointest Surg.
2011;15(1):209–14. doi:10.1007/s11605-010-1248-1.
15. Billio A, Pescosta N, Rosanelli C, Zanon GF, Gamba PG, Savastano S,
et al. Treatment of Kasabach-Merritt syndrome by embolisation of a
giant liver hemangioma. Am J Hematol. 2001;66(2):140–1. doi:10.1002/
1096-8652(200102)66:2<140::aid-ajh1031>3.0.co;2-5.
16. Suzuki H, Nimura Y, Kamiya J, Kondo S, Nagino M, Kanai M, et al.
Preoperative transcatheter arterial embolization for giant cavernous
hemangioma of the liver with consumption coagulopathy. Am J
Gastroenterol. 1997;92(4):688–91.
17. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for
life-threatening hemangiomas of infancy. N Engl J Med. 1992;326(22):1456–63.
doi:10.1056/nejm199205283262203.
18. Nako Y, Fukushima N, Igarashi T, Hoshino M, Sugiyama M, Tomomasa T,
et al. Successful interferon therapy in a neonate with life-threatening
Kasabach-Merritt syndrome. J Perinatol. 1997;17(3):244–7.
19. Gaspar L, Mascarenhas F, da Costa MS, Dias JS, Afonso JG, Silvestre ME.
Radiation therapy in the unresectable cavernous hemangioma of the liver.
Radiother Oncol. 1993;29(1):45–50.
20. Takahashi T, Kuwao S, Katagiri H, Kakita A. Multiple liver hemangiomas
enlargement during long-term steroid therapy for myasthenia gravis. Dig
Dis Sci. 1998;43(7):1553–61.
21. Gao J, Ke S, Ding XM, Zhou YM, Qian XJ, Sun WB. Radiofrequency ablation
for large hepatic hemangiomas: initial experience and lessons. Surgery.
2013;153(1):78–85. doi:10.1016/j.surg.2012.06.004.
22. Popescu I, Ciurea S, Brasoveanu V, Hrehoret D, Boeti P, Georgescu S, et al.
Liver hemangioma revisited: current surgical indications, technical aspects,
results. Hepatogastroenterology. 2001;48(39):770–6.
Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Yano et al. Surgical Case Reports  (2015) 1:93 Page 5 of 5
